Massachusetts General Hospital - Dana Farber is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital - Dana Farber has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer.
Sponsors: Merus B.V..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital - Dana Farber has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital - Dana Farber has 1 clinical trials on record, with 1 currently active. Their work covers Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer.
Massachusetts General Hospital - Dana Farber has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.